文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

SaVeBRAIN.Kids研究方案:一项在德国减少儿童轻度创伤性脑损伤住院的整群随机阶梯楔形试验

SaVeBRAIN.Kids-study protocol for a cluster-randomized stepped-wedge trial to reduce hospitalizations for mild traumatic brain injury in children in Germany.
PubMed 文献 · Trials · 2025-10-30

该试验采用整群随机阶梯楔形设计,在德国多中心实施并检验一种新护理路径,对年龄≥3个月且<18岁、格拉斯哥昏迷评分≥14分、无颅内并发症危险因素的轻度创伤性脑损伤患儿进行标准化风险评估、急诊结构化观察及技术支持的家庭监测,主要结局为住院相对风险和72小时内非计划再就诊比例,计划招募1390例患者。

要点

  • 研究对象为年龄≥3个月且<18岁、头部受伤48小时内就诊、格拉斯哥昏迷评分≥14分且无颅内并发症危险因素的患儿。
  • 新护理路径包括循证标准化风险评估、急诊数小时结构化观察和技术支持的家庭监测。
  • 共同主要结局为住院相对风险和门诊病例72小时内非计划再就诊比例。

核心结论

  • 该试验通过检验德国儿童轻度创伤性脑损伤管理的新方法,应对相关医疗挑战;若成功,干预可能大幅减少不必要的住院并释放住院能力,同时保持患者安全。

研究设计与样本

  • 非劣效性多中心整群随机阶梯楔形试验,所有中心起始为对照期并序贯转入干预期。
  • 计划在12个月内招募1390例患者,功效计算基于α=0.05、功效=0.9。
  • 纳入标准为年龄≥3个月且<18岁、头部受伤48小时内就诊、格拉斯哥昏迷评分≥14分且无颅内并发症危险因素。

主要发现

  • 共同主要结局为住院相对风险和门诊病例就诊后72小时内非计划再就诊比例。
  • 次要结局包括临床安全性指标、成本效果和过程评价。

关键数值与推荐

  • 共同主要结局为住院相对风险和门诊病例就诊后72小时内非计划再就诊比例。
  • 纳入标准要求格拉斯哥昏迷评分≥14分且无颅内并发症危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traumatic brain injury (TBI) is one of the most important pediatric conditions worldwide. In Germany, hospitalization rates for mild TBI drastically exceed hospitalization rates from similar healthcare systems. METHODS: The SaVeBRAIN.Kids trial will implement and test a novel care pathway (nCP) for evidence-based standardized risk assessment, structured observation in the emergency department (ED) for several hours, and technology-supported home monitoring with the aim to reduce hospitalizations. This non-inferiority multicenter study will be carried out using a cluster-randomized stepped-wedge design, with all centers starting in the control phase and sequentially transitioning to the intervention. Eligible participants (age ≥ 3 months and < 18 years) must present within 48 h of head injury, have minimal symptoms (Glasgow coma scale ≥ 14), and no risk factors for intracranial complications. The co-primary outcomes are the relative risk of hospitalization and the proportion of unplanned re-visits within 72 h of presentation to the ED for ambulatory cases. Secondary outcomes include clinical safety measures, cost-effectiveness, and process evaluation. Based on power calculations (α = 0.05, power = 0.9), 1390 patients will be recruited over 12 months. DISCUSSION: The SaVeBRAIN.Kids trial addresses a relevant healthcare challenge by testing a new approach to pediatric mild TBI management in Germany. It aligns with current evidence while accounting for the country's specific healthcare context. If successful, the intervention could substantially reduce unnecessary hospitalizations and free inpatient capacities while preserving patient safety. TRIAL REGISTRATION: German Clinical Trials Registry (DRKS00035623). Registered on January 21, 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bruns N, Brensing P, von der Heiden L, et al. SaVeBRAIN.Kids-study protocol for a cluster-randomized stepped-wedge trial to reduce hospitalizations for mild traumatic brain injury in children in Germany. Trials. 2025. PMID: 41168835. doi:10.1186/s13063-025-09240-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。